These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 29729901)
21. Loss of phosphatase and tensin homolog (PTEN) induces leptin-mediated leptin gene expression: feed-forward loop operating in the lung. Pathak RR; Grover A; Malaney P; Quarni W; Pandit A; Allen-Gipson D; Davé V J Biol Chem; 2013 Oct; 288(41):29821-35. PubMed ID: 23963458 [TBL] [Abstract][Full Text] [Related]
22. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR. Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640 [TBL] [Abstract][Full Text] [Related]
23. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma. Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788 [TBL] [Abstract][Full Text] [Related]
24. CFTR activation suppresses glioblastoma cell proliferation, migration and invasion. Zhong X; Chen HQ; Yang XL; Wang Q; Chen W; Li C Biochem Biophys Res Commun; 2019 Jan; 508(4):1279-1285. PubMed ID: 30573361 [TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells. Martinelli E; Troiani T; D'Aiuto E; Morgillo F; Vitagliano D; Capasso A; Costantino S; Ciuffreda LP; Merolla F; Vecchione L; De Vriendt V; Tejpar S; Nappi A; Sforza V; Martini G; Berrino L; De Palma R; Ciardiello F Int J Cancer; 2013 Nov; 133(9):2089-101. PubMed ID: 23629727 [TBL] [Abstract][Full Text] [Related]
26. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival. Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808 [TBL] [Abstract][Full Text] [Related]
27. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis. Zhang R; Banik NL; Ray SK Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures. Ivanov VN; Grabham PW; Wu CC; Hei TK Sci Rep; 2020 Feb; 10(1):2687. PubMed ID: 32060308 [TBL] [Abstract][Full Text] [Related]
29. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Tanwar MK; Gilbert MR; Holland EC Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041 [TBL] [Abstract][Full Text] [Related]
30. PTEN signaling pathways in glioblastoma. Koul D Cancer Biol Ther; 2008 Sep; 7(9):1321-5. PubMed ID: 18836294 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of the Invasion of Human Glioblastoma U87 Cell Line by Ruxolitinib: A Molecular Player of miR-17 and miR-20a Regulating JAK/STAT Pathway. Delen E; Doganlar O; Doganlar ZB; Delen O Turk Neurosurg; 2020; 30(2):182-189. PubMed ID: 31452174 [TBL] [Abstract][Full Text] [Related]
32. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Wiencke JK; Zheng S; Jelluma N; Tihan T; Vandenberg S; Tamgüney T; Baumber R; Parsons R; Lamborn KR; Berger MS; Wrensch MR; Haas-Kogan DA; Stokoe D Neuro Oncol; 2007 Jul; 9(3):271-9. PubMed ID: 17504928 [TBL] [Abstract][Full Text] [Related]
33. Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities. Filbin MG; Dabral SK; Pazyra-Murphy MF; Ramkissoon S; Kung AL; Pak E; Chung J; Theisen MA; Sun Y; Franchetti Y; Sun Y; Shulman DS; Redjal N; Tabak B; Beroukhim R; Wang Q; Zhao J; Dorsch M; Buonamici S; Ligon KL; Kelleher JF; Segal RA Nat Med; 2013 Nov; 19(11):1518-23. PubMed ID: 24076665 [TBL] [Abstract][Full Text] [Related]
34. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals. Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175 [TBL] [Abstract][Full Text] [Related]
35. Induction of autophagy biomarker BNIP3 requires a JAK2/STAT3 and MT1-MMP signaling interplay in Concanavalin-A-activated U87 glioblastoma cells. Pratt J; Annabi B Cell Signal; 2014 May; 26(5):917-24. PubMed ID: 24462646 [TBL] [Abstract][Full Text] [Related]
36. Modulation of PI3K/PTEN Pathway Does Not Affect Catalytic Activity of PDK1 in Jurkat Cells. Yang KJ; Piao L; Shin S; Shin SY; Li Y; Lee H; Tran Q; Park J; Hong S; Brazil DP; Hemmings BA; Kim SH; Park J Anticancer Res; 2017 Oct; 37(10):5415-5423. PubMed ID: 28982851 [TBL] [Abstract][Full Text] [Related]
37. PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1. Gont A; Hanson JE; Lavictoire SJ; Parolin DA; Daneshmand M; Restall IJ; Soucie M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA Oncotarget; 2013 Aug; 4(8):1266-79. PubMed ID: 23907540 [TBL] [Abstract][Full Text] [Related]
38. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma. Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539 [TBL] [Abstract][Full Text] [Related]
39. Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation. Xia Q; Zhang H; Zhang P; Li Y; Xu M; Li X; Li X; Dong L Oncogene; 2020 Sep; 39(36):5902-5915. PubMed ID: 32737433 [TBL] [Abstract][Full Text] [Related]
40. C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells. Guo P; Nie Q; Lan J; Ge J; Qiu Y; Mao Q Biochem Biophys Res Commun; 2013 Nov; 441(1):186-90. PubMed ID: 24140063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]